Overview

Effect of Add-on Montelukast to Inhaled Corticosteroids on Airway Responsiveness

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
Leukotriene receptor antagonists appear to posses additive anti-inflammatory effects to the effect of inhaled corticosteroids. Hypothesis: Treatment with oral montelukast will lower the dose-response plateau to inhaled methacholine in patients with mild to moderate persistent asthma treated with a stable dose of inhaled corticosteroids.
Phase:
Phase 4
Details
Lead Sponsor:
Hvidovre University Hospital
Treatments:
Montelukast